“…In summary, our data establish Mst signaling as a molecular rheostat to tune immunological signals and cellular and metabolic programs, which coordinately regulate the differentiation and effector programming of iNKT cells. Given that terminally mature S3 iNKT cells, which can establish residency within the thymus (Berzins et al, 2006), and memory CD8 + T cells both appear to favor OXPHOS over glycolysis, these findings highlight a conserved metabolic program that allows T cells to maintain their survival and long-term persistence, but also allows for rapid functional remodeling upon reactivation (Kumar et al, 2019). Further, the impaired ability of Mst1-deficient iNKT thymocytes to enter into a quiescent state is consistent with the accumulating evidence for dysregulated Hippo pathways with human cancers (Moroishi et al, 2015; Yu et al, 2015), which may be attributed to defective quiescence programs.…”